glp-1 receptor agonists brand names 5 trends to expect in 2026: Expanded uses, oral options, and more GLP-1 Drugs for Weight Loss:

Lancet (2025)

If youre new to medical weight loss, understanding What is Glucagon-Like Peptide-1 (GLP-1)

It demonstrated to have a safety profile similar to GLP-1RA not increasing the risk of hypoglycemia (48)

Over the last decade, pharmaceutical manufacturers have been producing improved versions of GLP-1 drugs to treat diabetes, obesity and most recently cardiovascular disease, marketed as Ozempic and Wegovy, among others

Precautions Supplements have not been approved by the FDA for medical use and generally lack solid clinical research

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study